Filing Details

Accession Number:
0001127602-20-013679
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-14 15:52:22
Reporting Period:
2020-04-13
Accepted Time:
2020-04-14 15:52:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1319872 Francis John Cogan 333 Lakeside Drive
Foster City CA 94404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-13 2,413 $19.63 57,273 No 4 M Direct
Common Stock Disposition 2020-04-13 2,413 $75.90 54,860 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2020-04-13 2,413 $0.00 2,413 $19.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,242 2020-05-11 No 4 M Direct
Footnotes
  1. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
  2. The options vested quarterly over the first year of service and were fully vested on May 11, 2011.